SVM Q1 2026 Earnings Modest EPS Beat Amid Silver Price Volatility Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines GSAT Q1 2026 Earnings EPS Misses Expectations Amidst Operational Challenges Oppenheimer Holdings Inc Q1 2025 Earnings Solid EPS Amid Quiet Revenue Disclosure Stock Slips BAC Q1 2026 Earnings Bank of America Beats on Strong Expense Control and Steady NII RNTX Q1 2026 Earnings EPS Beats Estimates as Preclinical Stage Biotech Tightens Spending